Fresenius Kabi: Multiple Rx Only Injections
Fresenius Kabi recalls injectables due to hair particulate matter.
Consumers should stop using the recalled products and contact Fresenius Kabi for instructions on returning the affected vials.
Why it was recalled
Fresenius Kabi is recalling multiple injectable products, including Glycopyrrolate Injection, Lidocaine HCl Injection, and Naropin, due to the presence of particulate matter (hair) found in the products. The recall affects specific lots of these sterile injectable medications.
Is mine affected?
Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.
Morphine Sulfate Injection USP, Simplist® 2 mg 1 mL, 1 mL fill in a single dose 1 mL Simplist® prefilled syringe
- Lot code
- 6402820
- Best-by
- 12/2028
- NDC
- 76045-004-01
- First Ship Date
- 01 29 2026
- Last Ship Date
- 06 09 2026
Where it was sold
Distributed nationwide.
Timeline
- Firm initiated recall
- Publicly announced
- Listed on Recall Canary
- Summary updated
Official source
Other Foreign Material recalls
Other recent recalls from Fresenius Kabi USA, LLC
Editorial summary by Recall Canary · summary updated 2026-09-03 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification